Inhibition of Aβ42 oligomerization in yeast by a PICALM ortholog and certain FDA approved drugs
The formation of small Aβ42 oligomers has been implicated as a toxic species in Alzheimer disease (AD). In strong support of this hypothesis we found that overexpression of Yap1802, the yeast ortholog of the human AD risk factor, phosphatidylinositol binding clathrin assembly protein (PICALM), reduc...
Main Authors: | Sei-Kyoung Park, Kiira Ratia, Mariam Ba, Maria Valencik, Susan W. Liebman |
---|---|
Format: | Article |
Language: | English |
Published: |
Shared Science Publishers OG
2016-01-01
|
Series: | Microbial Cell |
Subjects: | |
Online Access: | http://microbialcell.com/researcharticles/inhibition-of-a%CE%B242-oligomerization-in-yeast-by-a-picalm-ortholog-and-certain-fda-approved-drugs/ |
Similar Items
-
PICALM rs3851179 Variants Modulate Left Postcentral Cortex Thickness, CSF Amyloid β42, and Phosphorylated Tau in the Elderly
by: Zhiwei Wu, et al.
Published: (2022-12-01) -
PICALM and Alzheimer’s Disease: An Update and Perspectives
by: Kunie Ando, et al.
Published: (2022-12-01) -
PICALM::MLLT10 may indicate a new subgroup of acute leukemias with miscellaneous immunophenotype and poor initial treatment response but showing sensitivity to venetoclax
by: Haimin Sun, et al.
Published: (2024-06-01) -
Picalm, a novel regulator of GLUT4-trafficking in adipose tissue
by: Jasmin Gaugel, et al.
Published: (2024-10-01) -
Elevated Plasma Oligomeric Amyloid β-42 Is Associated with Cognitive Impairments in Cerebral Small Vessel Disease
by: Wensheng Qu, et al.
Published: (2023-01-01)